Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Duchenne Muscular Dystrophin (DMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03769116
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD)

Who this might be right for
Muscular Dystrophy, Duchenne
Sarepta Therapeutics, Inc. 41
Testing effectiveness (Phase 2)Ended earlyNCT03985878
What this trial is testing

Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) Who Have Completed Study 4658-102 (NCT03218995)

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00159250
What this trial is testing

Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Imperial College London 7
Early research (Phase 1)Study completedNCT02376816
What this trial is testing

Clinical Intramuscular Gene Transfer Trial of rAAVrh74.MCK.Micro-Dystrophin to Patients With Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Jerry R. Mendell 2
Testing effectiveness (Phase 2)Study completedNCT02439216
What this trial is testing

Phase 1/2 Study in Boys With Duchenne Muscular Dystrophy

Who this might be right for
Muscular Dystrophy, Duchenne
Catabasis Pharmaceuticals 31
Early research (Phase 1)Ended earlyNCT03362502
What this trial is testing

Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Pfizer 23
Testing effectiveness (Phase 2)Study completedNCT01396239
What this trial is testing

Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT03648827
What this trial is testing

Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)

Who this might be right for
Duchenne Muscular Dystrophy
PTC Therapeutics 20
Testing effectiveness (Phase 2)Study completedNCT03218995
What this trial is testing

Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 15
Not applicableLooking for participantsNCT07515235
What this trial is testing

DMD Gene Variants and Cardiac Dysfunction in Young Males With Dystrophinopathies

Who this might be right for
Duchenne Muscular Dystrophy (DMD)Becker Muscular DystrophyCardiomyopathy
Aristotle University Of Thessaloniki 65
Early research (Phase 1)Study completedNCT00428935
What this trial is testing

Safety Study of Mini-dystrophin Gene to Treat Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Nationwide Children's Hospital 6
Large-scale testing (Phase 3)Ended earlyNCT03917719
What this trial is testing

An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy
Catabasis Pharmaceuticals 130
Testing effectiveness (Phase 2)Study completedNCT02420379
What this trial is testing

Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
Sarepta Therapeutics, Inc. 33
Large-scale testing (Phase 3)Study completedNCT02255552
What this trial is testing

Study of Eteplirsen in DMD Patients

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
Sarepta Therapeutics, Inc. 109
Testing effectiveness (Phase 2)Ended earlyNCT06079736
What this trial is testing

PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping Treatment

Who this might be right for
Duchenne Muscular Dystrophy
PepGen Inc 7
Testing effectiveness (Phase 2)Study completedNCT00844597
What this trial is testing

Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 19
Testing effectiveness (Phase 2)Ended earlyNCT04004065
What this trial is testing

Two-Part Study for Dose Determination of Vesleteplirsen (SRP-5051) (Part A), Then Dose Expansion (Part B) in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment

Who this might be right for
Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc. 62
Very early researchLooking for participantsNCT07188012
What this trial is testing

Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
Shanghai Siponuoyin Biotechnology Co Ltd 9